3 assets in Folliculotropic Mycosis Fungoides

Therapeutic assets addressing Folliculotropic Mycosis Fungoides, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lenalidomide Folliculotropic Mycosis Fungoides	City of Hope Medical Center	P1/2	CCC (54)
Mogamulizumab Folliculotropic Mycosis Fungoides	City of Hope Medical Center	P2	CCC (53)
Durvalumab Folliculotropic Mycosis Fungoides	City of Hope Medical Center	P1/2	CCC (48)